Carcinoma of the breast is the most common non-skin malignancy in women. The p53 gene is one of the most commonly mutated genes described in human neoplasia. Mutant p53 protein has greater stability and longer half time than the wild type protein that can be detected by Immunohistochemistry. This study was conducted to evaluate the expression of p53 in breast carcinoma and its correlation with various histological prognostic markers to determine its significance as a prognostic marker in breast cancer. The prospective study included 52 modified radical mastectomy specimens diagnosed as breast cancer in the Department of Pathology at SRMSIMS, Bareilly between November 2016 and April 2018. Routine H&E staining and immunohistochemical analysis for ER, PR, Her2/neu and P53 was carried out in all the cases. Majority of the cases belonged to the age group 30-39 years and the most common cancer type was infiltrating ductal carcinoma. Significant correlation of p53 was observed with ER and PR expression, however no significant correlation could be found with tumor type, grade, size, type of margin, necrosis, stromal response, lymphovascular invasion, lymph node status and Her2/neu status.P53 was found to have a significant inverse correlation with ER and PR expression only. The results do not resolve whether detectable p53 protein expression represents a random product of dedifferentiation or an important feature of the malignant phenotype, playing a key role in tumor behavior.

No abstract

Author Consent Form (to be modified as applicable and signed copy attached with the manuscript) I/we hereby certify that I/we have participated sufficiently in the intellectual content, conception and design of this work or the analysis and interpretation of the data as well as the writing of the manuscript, to take public responsibility for it and have agreed to have our name listed as a contributor. I / we believe the manuscript represents valid work. Each author confirms they meet the criteria for authorship as established by the ICMJE. Neither this manuscript nor one with substantially similar content under my/our authorship has been published or is being considered for publication elsewhere, except as described in the covering letter. I/we certify that all the data collected during the study is presented in this manuscript and no data from the study has been or will be published separately.I/we give the rights to the corresponding author to make necessary changes as per the request of the Journal, do the rest of the corresponding on our behalf and will act as the guarantor for the manuscript on our behalf. The article will be publish under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) (https://creativecommons.org/licenses/by-nc-sa/4.0/) which allows others to reuse, copy and redistribute the material in any medium or format, and to alter or transform it, even commercially, as long as the author and original source are properly cited.The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. This transfer of publication rights covers the non-exclusive right to reproduction and distribute the article, including reprints, translations, photographic, reproductions, microform, electronic form (offline, online) or any other reproduction of similar nature. Financial interests, direct or indirect, that exist or may be perceived to exist for individual contributors in connection with the content of this paper have been disclosed in the cover letter. Sources of outside support of the project are named in the cover letter. The author may self-archive an author-created version of his article on his own website and his institutional repository.